Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00734175
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Not applicableStudy completedNCT00401700
What this trial is testing

Influenza Vaccine Postpartum Questionnaire

Who this might be right for
InfluenzaVaccinePregnancy
Unity Health Toronto 150
Large-scale testing (Phase 3)Active Not RecruitingNCT07229807
What this trial is testing

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

Who this might be right for
Influenza a
Guangdong Raynovent Biotech Co., Ltd 119
Large-scale testing (Phase 3)Ended earlyNCT00979667
What this trial is testing

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Who this might be right for
Upper Respiratory Tract InfectionInfluenza
Chinese University of Hong Kong 4
Not applicableStudy completedNCT00263900
What this trial is testing

TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit

Who this might be right for
InfluenzaRespiratory Syncytial Viruses
University Hospital, Rouen 377
Post-approval studies (Phase 4)Ended earlyNCT03686514
What this trial is testing

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics

Who this might be right for
Influenza
Emory University 39
Large-scale testing (Phase 3)Study completedNCT00319098
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
GlaxoSmithKline 5,075
Large-scale testing (Phase 3)Study completedNCT01610245
What this trial is testing

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Who this might be right for
Influenza
Romark Laboratories L.C. 1,941
Not applicableStudy completedNCT05524792
What this trial is testing

Incidence of Diabetes After a COVID-19 Infection

Who this might be right for
COVID-19Diabetes Mellitus
InGef - Institute for Applied Health Research Berlin GmbH 157,134
Not applicableStudy completedNCT06077045
What this trial is testing

Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases

Who this might be right for
Influenza
AstraZeneca 12,775,880
Not applicableStudy completedNCT02899065
What this trial is testing

Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

Who this might be right for
Influenza, Human
University of California, Davis 200
Testing effectiveness (Phase 2)Study completedNCT00294099
What this trial is testing

H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 600
Large-scale testing (Phase 3)Study completedNCT06060457
What this trial is testing

Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,900
Early research (Phase 1)Study completedNCT00730457
What this trial is testing

Phase 1 Safety and Immunogenicity Study in Healthy Adults of VAX125, a Recombinant HA-flagellin Influenza Vaccine

Who this might be right for
Influenza
VaxInnate Corporation 56
Not applicableStudy completedNCT01314911
What this trial is testing

Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 716
Post-approval studies (Phase 4)Study completedNCT01688921
What this trial is testing

Jet Injection for Influenza

Who this might be right for
Influenza, Human
PharmaJet, Inc. 1,250
Testing effectiveness (Phase 2)Study completedNCT00298233
What this trial is testing

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Who this might be right for
InfluenzaAvian InfluenzaSevere Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 326
Large-scale testing (Phase 3)Study completedNCT01000207
What this trial is testing

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

Who this might be right for
Swine-Origin Influenza A H1N1 Virus
Novartis Vaccines 123
Not applicableStudy completedNCT01868334
What this trial is testing

SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM

Who this might be right for
Adult Influenza VaccinationsAdult PPSV VaccinationsAdult Tdap/Td Vaccinations
University of Pittsburgh 70,549
Post-approval studies (Phase 4)UnknownNCT01980836
What this trial is testing

Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine

Who this might be right for
Rheumatoid ArthritisCellular Immune Response
Tel-Aviv Sourasky Medical Center 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation